TABLE 2.
Therapeutic effects of exosomes in OA.
Exosomes | Target cells | Mechanisms | Biological effects on OA | References |
---|---|---|---|---|
BMSCs-derived exosomes | Osteoarthritic chondrocytes | ERK, AKT and p38 pathways | Protect chondrocytes from apoptosis | (Fukai et al., 2012; Cosenza et al., 2017; Qi et al., 2019; Jin et al., 2020) |
Synovial fibroblasts | Upregulate the expression of anabolic markers genes and decrease catabolic and inflammatory markers genes | Facilitate the repair of injured cartilage and subchondral bone | ||
Macrophages | MiR-26a-5p/PTGS2 pathway | Accelerate damage of synovial fibroblasts | ||
Suppress activities of synovial fibroblasts and macrophages | ||||
AMSCs-derived exosomes | Osteoarthritis chondrocytes | Upregulate cytokine IL-10 and collagen II and decrease proinflammatory mediators | Cartilage regeneration and inflammatory modulation | Tofiño-Vian et al. (2018) |
SMSCs-derived exosomes | Articular chondrocytes | WNT5a/WNT5b/YAP way | Stimulate the proliferation and movement of chondrocytes | (Koizumi et al., 2016; Tao et al., 2017b; Zhu et al., 2017) |
MiR-140-5p mediated protection of ECM in vitro | Facilitate cartilage regeneration and suppress OA progression | |||
Regulate bone remodeling | ||||
EMSCs-derived exosomes | Osteoarthritic chondrocytes | Balance the synthesis and degradation of cartilage matrix | Prevent the development of cartilage destruction | (Tan et al., 2014; Zhang et al., 2016) |
Regeneration of cartilage and subchondral bone | ||||
hUSCs-derived exosomes | Osteoarthritic chondrocytes | Decrease the expression of endothelial growth factor A (VEGFA) gene | Promote the proliferation and migration capacity of OA chondrocytes | Liu et al. (2022b) |
Suppress the apoptosis of OA chondrocytes | ||||
iPSCs-derived exosomes | Osteoarthritic chondrocytes | Unknown | Stimulate the proliferation and migration of chondrocytes | Zhu et al. (2017) |
AFSCs-derived exosomes | Osteoarthritic chondrocytes | TGF-β and IDO mediated immunosuppressive | Cartilage repair | Zavatti et al. (2020) |
Promote M2 polarization | ||||
UMSCs-derived exosomes | Osteoarthritic chondrocytes | MiR-100-5p/NOX4 signaling pathway | Alleviate apoptosis | Yan and Wu, (2020) |
ASCs-derived exosomes | Human stem cells | Regulation of genes expression by upstream regulatory pathways | Bone and cartilage regeneration | Lei et al. (2022) |
PRP-Exos | Osteoarthritic chondrocyte | WNT/β-catenin signaling pathway | Stimulate chondrocytes proliferation and migration | Liu et al. (2019) |
Decrease OA chondrocytes apoptosis | ||||
IPFP-Exos | Osteoarthritic chondrocytes | MiR-100-5p and its downstream pathway mediated downregulation of mTOR. | Reduce articular cartilage destruction | (Wu et al., 2019; Li et al., 2021a) |
Improve gait function | ||||
Chondrocytes-derived exosomes | Osteoarthritic chondrocytes | Promote M2 macrophage infiltration | Restore the metabolism of degenerative chondrocytes | Zheng et al. (2019) |
Modulate immune reactivity | ||||
SFCs-derived exosomes | Osteoarthritic chondrocytes |
MiR-126-3p mediated anti-inflammatory signaling | Suppress chondrocyte inflammation and cartilage degradation | Zhou et al. (2021) |
Decrease the production of proinflammatory cytokine |